TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2020 DA - 2020// TI - Cancer statistics, 2020 JO - CA Cancer J Clin VL - 70 UR - https://doi.org/10.3322/caac.21590 DO - 10.3322/caac.21590 ID - Siegel2020 ER - TY - JOUR AU - Kato, T. AU - Hwang, R. AU - Liou, P. PY - 2020 DA - 2020// TI - Ex vivo resection and autotransplantation for conventionally Unresectable tumors - an 11-year single center experience JO - Ann Surg VL - 272 UR - https://doi.org/10.1097/SLA.0000000000004270 DO - 10.1097/SLA.0000000000004270 ID - Kato2020 ER - TY - JOUR AU - Hoff, D. D. AU - Ervin, T. AU - Arena, F. P. PY - 2013 DA - 2013// TI - Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1304369 DO - 10.1056/NEJMoa1304369 ID - Hoff2013 ER - TY - JOUR AU - Paget, S. PY - 1989 DA - 1989// TI - The distribution of secondary growths in cancer of the breast. 1889 JO - Cancer Metastasis Rev VL - 8 ID - Paget1989 ER - TY - JOUR AU - Liu, Y. AU - Cao, X. PY - 2016 DA - 2016// TI - Characteristics and significance of the pre-metastatic niche JO - Cancer Cell VL - 30 UR - https://doi.org/10.1016/j.ccell.2016.09.011 DO - 10.1016/j.ccell.2016.09.011 ID - Liu2016 ER - TY - JOUR AU - Ioannides, C. G. AU - Whiteside, T. L. PY - 1993 DA - 1993// TI - T cell recognition of human tumors: implications for molecular immunotherapy of cancer JO - Clin Immunol Immunopathol VL - 66 UR - https://doi.org/10.1006/clin.1993.1012 DO - 10.1006/clin.1993.1012 ID - Ioannides1993 ER - TY - JOUR AU - Albini, A. AU - Magnani, E. AU - Noonan, D. M. PY - 2010 DA - 2010// TI - The tumor microenvironment: biology of a complex cellular and tissue society JO - Q J Nucl Med Mol Imaging VL - 54 ID - Albini2010 ER - TY - JOUR AU - Weston, W. W. AU - Ganey, T. AU - Temple, H. T. PY - 2019 DA - 2019// TI - The relationship between Exosomes and Cancer: implications for diagnostics and therapeutics JO - BioDrugs. VL - 33 UR - https://doi.org/10.1007/s40259-019-00338-5 DO - 10.1007/s40259-019-00338-5 ID - Weston2019 ER - TY - JOUR AU - Muller, P. A. AU - Vousden, K. H. PY - 2014 DA - 2014// TI - Mutant p53 in cancer: new functions and therapeutic opportunities JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2014.01.021 DO - 10.1016/j.ccr.2014.01.021 ID - Muller2014 ER - TY - JOUR AU - Olive, K. P. AU - Tuveson, D. A. AU - Ruhe, Z. C. PY - 2004 DA - 2004// TI - Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome JO - Cell. VL - 119 UR - https://doi.org/10.1016/j.cell.2004.11.004 DO - 10.1016/j.cell.2004.11.004 ID - Olive2004 ER - TY - JOUR AU - Hientz, K. AU - Mohr, A. AU - Bhakta-Guha, D. AU - Efferth, T. PY - 2017 DA - 2017// TI - The role of p53 in cancer drug resistance and targeted chemotherapy JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.13475 DO - 10.18632/oncotarget.13475 ID - Hientz2017 ER - TY - JOUR AU - Tahmasebi Birgani, M. AU - Carloni, V. PY - 2017 DA - 2017// TI - Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18020405 DO - 10.3390/ijms18020405 ID - Tahmasebi Birgani2017 ER - TY - JOUR AU - Schaafsma, E. AU - Yuan, Y. AU - Zhao, Y. AU - Cheng, C. PY - 2019 DA - 2019// TI - Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-54791-x DO - 10.1038/s41598-019-54791-x ID - Schaafsma2019 ER - TY - JOUR AU - Panni, R. Z. AU - Sanford, D. E. AU - Belt, B. A. PY - 2014 DA - 2014// TI - Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1527-x DO - 10.1007/s00262-014-1527-x ID - Panni2014 ER - TY - JOUR AU - Takaishi, K. AU - Komohara, Y. AU - Tashiro, H. PY - 2010 DA - 2010// TI - Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01652.x DO - 10.1111/j.1349-7006.2010.01652.x ID - Takaishi2010 ER - TY - JOUR AU - Yue, C. AU - Shen, S. AU - Deng, J. PY - 2015 DA - 2015// TI - STAT3 in CD8+ T cells inhibits their tumor accumulation by Downregulating CXCR3/CXCL10 Axis JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-15-0014 DO - 10.1158/2326-6066.CIR-15-0014 ID - Yue2015 ER - TY - JOUR AU - D'Amico, S. AU - Shi, J. AU - Martin, B. L. AU - Crawford, H. C. AU - Petrenko, O. AU - Reich, N. C. PY - 2018 DA - 2018// TI - STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis JO - Genes Dev VL - 32 UR - https://doi.org/10.1101/gad.311852.118 DO - 10.1101/gad.311852.118 ID - D'Amico2018 ER - TY - JOUR AU - Yang, X. AU - Lin, Y. AU - Shi, Y. PY - 2016 DA - 2016// TI - FAP promotes immunosuppression by Cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2973 DO - 10.1158/0008-5472.CAN-15-2973 ID - Yang2016 ER - TY - JOUR AU - Butler, J. M. AU - Kobayashi, H. AU - Rafii, S. PY - 2010 DA - 2010// TI - Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2791 DO - 10.1038/nrc2791 ID - Butler2010 ER - TY - JOUR AU - Junttila, M. R. AU - Sauvage, F. J. PY - 2013 DA - 2013// TI - Influence of tumour micro-environment heterogeneity on therapeutic response JO - Nature. VL - 501 UR - https://doi.org/10.1038/nature12626 DO - 10.1038/nature12626 ID - Junttila2013 ER - TY - JOUR AU - Maishi, N. AU - Hida, K. PY - 2017 DA - 2017// TI - Tumor endothelial cells accelerate tumor metastasis JO - Cancer Sci VL - 108 UR - https://doi.org/10.1111/cas.13336 DO - 10.1111/cas.13336 ID - Maishi2017 ER - TY - JOUR AU - Yuan, Y. AU - Jiang, Y. C. AU - Sun, C. K. AU - Chen, Q. M. PY - 2016 DA - 2016// TI - Role of the tumor microenvironment in tumor progression and the clinical applications (review) JO - Oncol Rep VL - 35 UR - https://doi.org/10.3892/or.2016.4660 DO - 10.3892/or.2016.4660 ID - Yuan2016 ER - TY - JOUR AU - Bekes, E. M. AU - Schweighofer, B. AU - Kupriyanova, T. A. PY - 2011 DA - 2011// TI - Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation JO - Am J Pathol VL - 179 UR - https://doi.org/10.1016/j.ajpath.2011.05.031 DO - 10.1016/j.ajpath.2011.05.031 ID - Bekes2011 ER - TY - JOUR AU - Wada, Y. AU - Yoshida, K. AU - Tsutani, Y. PY - 2007 DA - 2007// TI - Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines JO - Oncol Rep VL - 17 ID - Wada2007 ER - TY - JOUR AU - Yin, Y. AU - Yao, S. AU - Hu, Y. PY - 2017 DA - 2017// TI - The immune-microenvironment confers Chemoresistance of colorectal Cancer through macrophage-derived IL6 JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-17-1283 DO - 10.1158/1078-0432.CCR-17-1283 ID - Yin2017 ER - TY - JOUR AU - Quail, D. F. AU - Joyce, J. A. PY - 2013 DA - 2013// TI - Microenvironmental regulation of tumor progression and metastasis JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3394 DO - 10.1038/nm.3394 ID - Quail2013 ER - TY - JOUR AU - Chen, Z. AU - Zhou, L. AU - Liu, L. PY - 2020 DA - 2020// TI - Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-020-18916-5 DO - 10.1038/s41467-020-18916-5 ID - Chen2020 ER - TY - JOUR AU - Gehmert, S. AU - Lehoczky, G. AU - Loibl, M. AU - Jung, F. AU - Prantl, L. AU - Gehmert, S. PY - 2020 DA - 2020// TI - Interaction between extracellular cancer matrix and stromal breast cells JO - Clin Hemorheol Microcirc VL - 74 UR - https://doi.org/10.3233/CH-199234 DO - 10.3233/CH-199234 ID - Gehmert2020 ER - TY - JOUR AU - Urooj, T. AU - Wasim, B. AU - Mushtaq, S. AU - Shah, S. N. N. AU - Shah, M. PY - 2020 DA - 2020// TI - Cancer cell-derived secretory factors in breast Cancer-associated lung metastasis: their mechanism and future prospects JO - Curr Cancer Drug Targets VL - 20 UR - https://doi.org/10.2174/1568009620666191220151856 DO - 10.2174/1568009620666191220151856 ID - Urooj2020 ER - TY - JOUR AU - Nagarsheth, N. AU - Wicha, M. S. AU - Zou, W. PY - 2017 DA - 2017// TI - Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy JO - Nat Rev Immunol VL - 17 UR - https://doi.org/10.1038/nri.2017.49 DO - 10.1038/nri.2017.49 ID - Nagarsheth2017 ER - TY - JOUR AU - Lin, N. AU - Meng, L. AU - Lin, J. PY - 2020 DA - 2020// TI - Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1 JO - J Cell Biochem VL - 121 UR - https://doi.org/10.1002/jcb.29380 DO - 10.1002/jcb.29380 ID - Lin2020 ER - TY - JOUR AU - Becker, A. AU - Thakur, B. K. AU - Weiss, J. M. AU - Kim, H. S. AU - Peinado, H. AU - Lyden, D. PY - 2016 DA - 2016// TI - Extracellular vesicles in Cancer: cell-to-cell mediators of metastasis JO - Cancer Cell VL - 30 UR - https://doi.org/10.1016/j.ccell.2016.10.009 DO - 10.1016/j.ccell.2016.10.009 ID - Becker2016 ER - TY - JOUR AU - Palma, M. AU - Biziato, D. AU - Petrova, T. V. PY - 2017 DA - 2017// TI - Microenvironmental regulation of tumour angiogenesis JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.51 DO - 10.1038/nrc.2017.51 ID - Palma2017 ER - TY - JOUR AU - Keklikoglou, I. AU - Cianciaruso, C. AU - Güç, E. PY - 2019 DA - 2019// TI - Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models JO - Nat Cell Biol VL - 21 UR - https://doi.org/10.1038/s41556-018-0256-3 DO - 10.1038/s41556-018-0256-3 ID - Keklikoglou2019 ER - TY - JOUR AU - Cianciaruso, C. AU - Beltraminelli, T. AU - Duval, F. PY - 2019 DA - 2019// TI - Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles JO - Cell Rep VL - 27 UR - https://doi.org/10.1016/j.celrep.2019.05.008 DO - 10.1016/j.celrep.2019.05.008 ID - Cianciaruso2019 ER - TY - JOUR AU - Ji, Q. AU - Zhou, L. AU - Sui, H. PY - 2020 DA - 2020// TI - Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-020-14869-x DO - 10.1038/s41467-020-14869-x ID - Ji2020 ER - TY - JOUR AU - Fletcher, M. AU - Ramirez, M. E. AU - Sierra, R. A. PY - 2015 DA - 2015// TI - L-arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-1491 DO - 10.1158/0008-5472.CAN-14-1491 ID - Fletcher2015 ER - TY - JOUR AU - Meng, W. AU - Hao, Y. AU - He, C. AU - Li, L. AU - Zhu, G. PY - 2019 DA - 2019// TI - Exosome-orchestrated hypoxic tumor microenvironment JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0982-6 DO - 10.1186/s12943-019-0982-6 ID - Meng2019 ER - TY - JOUR AU - Zhang, X. AU - Sai, B. AU - Wang, F. PY - 2019 DA - 2019// TI - Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0959-5 DO - 10.1186/s12943-019-0959-5 ID - Zhang2019 ER - TY - JOUR AU - Martin, J. D. AU - Fukumura, D. AU - Duda, D. G. AU - Boucher, Y. AU - Jain, R. K. PY - 2016 DA - 2016// TI - Reengineering the tumor microenvironment to alleviate hypoxia and overcome Cancer heterogeneity JO - Cold Spring Harb Perspect Med VL - 6 UR - https://doi.org/10.1101/cshperspect.a027094 DO - 10.1101/cshperspect.a027094 ID - Martin2016 ER - TY - JOUR AU - Jing, X. AU - Yang, F. AU - Shao, C. PY - 2019 DA - 2019// TI - Role of hypoxia in cancer therapy by regulating the tumor microenvironment JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1089-9 DO - 10.1186/s12943-019-1089-9 ID - Jing2019 ER - TY - JOUR AU - Herrera, M. AU - Galindo-Pumariño, C. AU - García-Barberán, V. AU - Peña, C. PY - 2019 DA - 2019// TI - A snapshot of the tumor microenvironment in colorectal Cancer: the liquid biopsy JO - Int J Mol Sci VL - 20 UR - https://doi.org/10.3390/ijms20236016 DO - 10.3390/ijms20236016 ID - Herrera2019 ER - TY - JOUR AU - Liu, Y. AU - Gu, Y. AU - Cao, X. PY - 2015 DA - 2015// TI - The exosomes in tumor immunity JO - Oncoimmunology. VL - 4 UR - https://doi.org/10.1080/2162402X.2015.1027472 DO - 10.1080/2162402X.2015.1027472 ID - Liu2015 ER - TY - JOUR AU - Wortzel, I. AU - Dror, S. AU - Kenific, C. M. AU - Lyden, D. PY - 2019 DA - 2019// TI - Exosome-mediated metastasis: communication from a distance JO - Dev Cell VL - 49 UR - https://doi.org/10.1016/j.devcel.2019.04.011 DO - 10.1016/j.devcel.2019.04.011 ID - Wortzel2019 ER - TY - JOUR AU - Shao, Y. AU - Chen, T. AU - Zheng, X. PY - 2018 DA - 2018// TI - Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis JO - Carcinogenesis. VL - 39 UR - https://doi.org/10.1093/carcin/bgy115 DO - 10.1093/carcin/bgy115 ID - Shao2018 ER - TY - JOUR AU - Guo, Y. AU - Ji, X. AU - Liu, J. PY - 2019 DA - 2019// TI - Effects of exosomes on pre-metastatic niche formation in tumors JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0995-1 DO - 10.1186/s12943-019-0995-1 ID - Guo2019 ER - TY - JOUR AU - Song, H. AU - Wang, T. AU - Tian, L. PY - 2019 DA - 2019// TI - Macrophages on the peritoneum are involved in gastric Cancer peritoneal metastasis JO - J Cancer VL - 10 UR - https://doi.org/10.7150/jca.31787 DO - 10.7150/jca.31787 ID - Song2019 ER - TY - JOUR AU - Du, X. AU - Xu, Q. AU - Pan, D. PY - 2019 DA - 2019// TI - HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression JO - Cell Death Dis VL - 10 UR - https://doi.org/10.1038/s41419-019-2114-z DO - 10.1038/s41419-019-2114-z ID - Du2019 ER - TY - JOUR AU - Pearson, G. W. PY - 2019 DA - 2019// TI - Control of invasion by epithelial-to-Mesenchymal transition programs during metastasis JO - J Clin Med VL - 8 UR - https://doi.org/10.3390/jcm8050646 DO - 10.3390/jcm8050646 ID - Pearson2019 ER - TY - JOUR AU - Micalizzi, D. S. AU - Maheswaran, S. AU - Haber, D. A. PY - 2017 DA - 2017// TI - A conduit to metastasis: circulating tumor cell biology JO - Genes Dev VL - 31 UR - https://doi.org/10.1101/gad.305805.117 DO - 10.1101/gad.305805.117 ID - Micalizzi2017 ER - TY - JOUR AU - Massagué, J. AU - Obenauf, A. C. PY - 2016 DA - 2016// TI - Metastatic colonization by circulating tumour cells JO - Nature. VL - 529 UR - https://doi.org/10.1038/nature17038 DO - 10.1038/nature17038 ID - Massagué2016 ER - TY - JOUR AU - Lamouille, S. AU - Xu, J. AU - Derynck, R. PY - 2014 DA - 2014// TI - Molecular mechanisms of epithelial-mesenchymal transition JO - Nat Rev Mol Cell Biol VL - 15 UR - https://doi.org/10.1038/nrm3758 DO - 10.1038/nrm3758 ID - Lamouille2014 ER - TY - JOUR AU - Plaks, V. AU - Kong, N. AU - Werb, Z. PY - 2015 DA - 2015// TI - The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? JO - Cell Stem Cell VL - 16 UR - https://doi.org/10.1016/j.stem.2015.02.015 DO - 10.1016/j.stem.2015.02.015 ID - Plaks2015 ER - TY - JOUR AU - Yu, H. AU - Lee, H. AU - Herrmann, A. AU - Buettner, R. AU - Jove, R. PY - 2014 DA - 2014// TI - Revisiting STAT3 signalling in cancer: new and unexpected biological functions JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3818 DO - 10.1038/nrc3818 ID - Yu2014 ER - TY - JOUR AU - Tao, W. AU - Chu, C. AU - Zhou, W. PY - 2020 DA - 2020// TI - Dual role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-020-16827-z DO - 10.1038/s41467-020-16827-z ID - Tao2020 ER - TY - JOUR AU - Uehara, I. AU - Tanaka, N. PY - 2018 DA - 2018// TI - Role of p53 in the regulation of the inflammatory tumor microenvironment and tumor suppression JO - Cancers (Basel). VL - 10 UR - https://doi.org/10.3390/cancers10070219 DO - 10.3390/cancers10070219 ID - Uehara2018 ER - TY - JOUR AU - Lu, Z. AU - Zou, J. AU - Li, S. PY - 2020 DA - 2020// TI - Epigenetic therapy inhibits metastases by disrupting premetastatic niches JO - Nature. VL - 579 UR - https://doi.org/10.1038/s41586-020-2054-x DO - 10.1038/s41586-020-2054-x ID - Lu2020 ER - TY - JOUR AU - Kitamura, T. AU - Qian, B. Z. AU - Pollard, J. W. PY - 2015 DA - 2015// TI - Immune cell promotion of metastasis JO - Nat Rev Immunol. VL - 15 UR - https://doi.org/10.1038/nri3789 DO - 10.1038/nri3789 ID - Kitamura2015 ER - TY - JOUR AU - Liu, Y. AU - Cao, X. PY - 2016 DA - 2016// TI - Immunosuppressive cells in tumor immune escape and metastasis JO - J Mol Med (Berl) VL - 94 UR - https://doi.org/10.1007/s00109-015-1376-x DO - 10.1007/s00109-015-1376-x ID - Liu2016 ER - TY - JOUR AU - Tan, H. X. AU - Gong, W. Z. AU - Zhou, K. PY - 2020 DA - 2020// TI - CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer JO - Cancer Biol Ther VL - 21 UR - https://doi.org/10.1080/15384047.2019.1685157 DO - 10.1080/15384047.2019.1685157 ID - Tan2020 ER - TY - JOUR AU - Du, L. AU - Han, X. G. AU - Tu, B. PY - 2018 DA - 2018// TI - CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-018-0745-0 DO - 10.1038/s41419-018-0745-0 ID - Du2018 ER - TY - JOUR AU - Facciabene, A. AU - Peng, X. AU - Hagemann, I. S. PY - 2011 DA - 2011// TI - Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells JO - Nature. VL - 475 UR - https://doi.org/10.1038/nature10169 DO - 10.1038/nature10169 ID - Facciabene2011 ER - TY - JOUR AU - Corzo, C. A. AU - Condamine, T. AU - Lu, L. PY - 2010 DA - 2010// TI - HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20100587 DO - 10.1084/jem.20100587 ID - Corzo2010 ER - TY - JOUR AU - Li, M. AU - Qi, Y. AU - Chen, M. PY - 2019 DA - 2019// TI - GATA binding protein 3 boosts extracellular ATP hydrolysis and inhibits metastasis of breast Cancer by up-regulating Ectonucleoside triphosphate Diphosphohydrolase 3 JO - Int J Biol Sci VL - 15 UR - https://doi.org/10.7150/ijbs.35563 DO - 10.7150/ijbs.35563 ID - Li2019 ER - TY - JOUR AU - Jiang, L. H. AU - Mousawi, F. AU - Yang, X. AU - Roger, S. PY - 2017 DA - 2017// TI - ATP-induced Ca2+−signalling mechanisms in the regulation of mesenchymal stem cell migration JO - Cell Mol Life Sci VL - 74 UR - https://doi.org/10.1007/s00018-017-2545-6 DO - 10.1007/s00018-017-2545-6 ID - Jiang2017 ER - TY - JOUR AU - Neophytou, C. M. AU - Kyriakou, T. C. AU - Papageorgis, P. PY - 2019 DA - 2019// TI - Mechanisms of metastatic tumor dormancy and implications for Cancer therapy JO - Int J Mol Sci VL - 20 UR - https://doi.org/10.3390/ijms20246158 DO - 10.3390/ijms20246158 ID - Neophytou2019 ER - TY - JOUR AU - Milette, S. AU - Sicklick, J. K. AU - Lowy, A. M. AU - Brodt, P. PY - 2017 DA - 2017// TI - Molecular pathways: targeting the microenvironment of liver metastases JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-15-1636 DO - 10.1158/1078-0432.CCR-15-1636 ID - Milette2017 ER - TY - JOUR AU - Pein, M. AU - Insua-Rodríguez, J. AU - Hongu, T. PY - 2020 DA - 2020// TI - Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-020-15188-x DO - 10.1038/s41467-020-15188-x ID - Pein2020 ER - TY - JOUR AU - Li, Q. AU - Zhu, C. C. AU - Ni, B. PY - 2019 DA - 2019// TI - Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts JO - EBioMedicine. VL - 49 UR - https://doi.org/10.1016/j.ebiom.2019.10.037 DO - 10.1016/j.ebiom.2019.10.037 ID - Li2019 ER - TY - JOUR AU - Vander Heiden, M. G. AU - Cantley, L. C. AU - Thompson, C. B. PY - 2009 DA - 2009// TI - Understanding the Warburg effect: the metabolic requirements of cell proliferation JO - Science. VL - 324 UR - https://doi.org/10.1126/science.1160809 DO - 10.1126/science.1160809 ID - Vander Heiden2009 ER - TY - JOUR AU - Yang, L. AU - Achreja, A. AU - Yeung, T. L. PY - 2016 DA - 2016// TI - Targeting stromal glutamine Synthetase in tumors disrupts tumor microenvironment-regulated Cancer cell growth JO - Cell Metab VL - 24 UR - https://doi.org/10.1016/j.cmet.2016.10.011 DO - 10.1016/j.cmet.2016.10.011 ID - Yang2016 ER - TY - JOUR AU - Meads, M. B. AU - Gatenby, R. A. AU - Dalton, W. S. PY - 2009 DA - 2009// TI - Environment-mediated drug resistance: a major contributor to minimal residual disease JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2714 DO - 10.1038/nrc2714 ID - Meads2009 ER - TY - JOUR AU - Heldin, C. H. AU - Rubin, K. AU - Pietras, K. AU - Ostman, A. PY - 2004 DA - 2004// TI - High interstitial fluid pressure - an obstacle in cancer therapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1456 DO - 10.1038/nrc1456 ID - Heldin2004 ER - TY - JOUR AU - Kaplan, R. N. AU - Riba, R. D. AU - Zacharoulis, S. PY - 2005 DA - 2005// TI - VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche JO - Nature. VL - 438 UR - https://doi.org/10.1038/nature04186 DO - 10.1038/nature04186 ID - Kaplan2005 ER - TY - JOUR AU - Gao, H. AU - Chakraborty, G. AU - Lee-Lim, A. P. PY - 2012 DA - 2012// TI - The BMP inhibitor coco reactivates breast cancer cells at lung metastatic sites JO - Cell. VL - 150 UR - https://doi.org/10.1016/j.cell.2012.06.035 DO - 10.1016/j.cell.2012.06.035 ID - Gao2012 ER - TY - JOUR AU - Yoshikawa, K. AU - Mitsunaga, S. AU - Kinoshita, T. PY - 2012 DA - 2012// TI - Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02411.x DO - 10.1111/j.1349-7006.2012.02411.x ID - Yoshikawa2012 ER - TY - JOUR AU - Wu, T. AU - Dai, Y. PY - 2017 DA - 2017// TI - Tumor microenvironment and therapeutic response JO - Cancer Lett VL - 387 UR - https://doi.org/10.1016/j.canlet.2016.01.043 DO - 10.1016/j.canlet.2016.01.043 ID - Wu2017 ER - TY - JOUR AU - Margolin, D. A. AU - Silinsky, J. AU - Grimes, C. PY - 2011 DA - 2011// TI - Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling JO - Neoplasia. VL - 13 UR - https://doi.org/10.1593/neo.11324 DO - 10.1593/neo.11324 ID - Margolin2011 ER - TY - JOUR AU - Zigrino, P. AU - Nischt, R. AU - Mauch, C. PY - 2011 DA - 2011// TI - The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M110.168617 DO - 10.1074/jbc.M110.168617 ID - Zigrino2011 ER - TY - JOUR AU - Bruchard, M. AU - Mignot, G. AU - Derangère, V. PY - 2013 DA - 2013// TI - Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.2999 DO - 10.1038/nm.2999 ID - Bruchard2013 ER - TY - JOUR AU - Höpken, U. E. AU - Rehm, A. PY - 2012 DA - 2012// TI - Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs JO - J Mol Med (Berl). VL - 90 UR - https://doi.org/10.1007/s00109-012-0906-z DO - 10.1007/s00109-012-0906-z ID - Höpken2012 ER - TY - JOUR AU - Hacken, E. AU - Burger, J. A. PY - 2016 DA - 2016// TI - Microenvironment interactions and B-cell receptor signaling in chronic lymphocytic leukemia: implications for disease pathogenesis and treatment JO - Biochim Biophys Acta VL - 1863 UR - https://doi.org/10.1016/j.bbamcr.2015.07.009 DO - 10.1016/j.bbamcr.2015.07.009 ID - Hacken2016 ER - TY - JOUR AU - Höpken, U. E. AU - Rehm, A. PY - 2019 DA - 2019// TI - Targeting the tumor microenvironment of leukemia and lymphoma JO - Trends Cancer VL - 5 UR - https://doi.org/10.1016/j.trecan.2019.05.001 DO - 10.1016/j.trecan.2019.05.001 ID - Höpken2019 ER - TY - JOUR AU - Müller, G. AU - Höpken, U. E. AU - Lipp, M. PY - 2003 DA - 2003// TI - The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity JO - Immunol Rev VL - 195 UR - https://doi.org/10.1034/j.1600-065X.2003.00073.x DO - 10.1034/j.1600-065X.2003.00073.x ID - Müller2003 ER - TY - JOUR AU - Fowler, N. H. AU - Nastoupil, L. J. AU - Hagemeister, F. B. PY - 2015 DA - 2015// TI - Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma JO - Haematologica. VL - 100 UR - https://doi.org/10.3324/haematol.2015.131144 DO - 10.3324/haematol.2015.131144 ID - Fowler2015 ER - TY - JOUR AU - Galluzzi, L. AU - Buqué, A. AU - Kepp, O. AU - Zitvogel, L. AU - Kroemer, G. PY - 2015 DA - 2015// TI - Immunological effects of conventional chemotherapy and targeted anticancer agents JO - Cancer Cell VL - 28 UR - https://doi.org/10.1016/j.ccell.2015.10.012 DO - 10.1016/j.ccell.2015.10.012 ID - Galluzzi2015 ER - TY - JOUR AU - Zitvogel, L. AU - Galluzzi, L. AU - Smyth, M. J. AU - Kroemer, G. PY - 2013 DA - 2013// TI - Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance JO - Immunity. VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.06.014 DO - 10.1016/j.immuni.2013.06.014 ID - Zitvogel2013 ER - TY - JOUR AU - Gotwals, P. AU - Cameron, S. AU - Cipolletta, D. PY - 2017 DA - 2017// TI - Prospects for combining targeted and conventional cancer therapy with immunotherapy JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.17 DO - 10.1038/nrc.2017.17 ID - Gotwals2017 ER - TY - JOUR AU - Deng, C. AU - Xu, Y. AU - Fu, J. PY - 2020 DA - 2020// TI - Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma JO - Cancer Sci VL - 111 UR - https://doi.org/10.1111/cas.14398 DO - 10.1111/cas.14398 ID - Deng2020 ER - TY - JOUR AU - Winterhoff, B. AU - Freyer, L. AU - Hammond, E. PY - 2015 DA - 2015// TI - PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.02.007 DO - 10.1016/j.ejca.2015.02.007 ID - Winterhoff2015 ER - TY - JOUR AU - Aiello, N. M. AU - Bajor, D. L. AU - Norgard, R. J. PY - 2016 DA - 2016// TI - Metastatic progression is associated with dynamic changes in the local microenvironment JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms12819 DO - 10.1038/ncomms12819 ID - Aiello2016 ER - TY - JOUR AU - Xing, F. AU - Liu, Y. AU - Wu, S. Y. PY - 2018 DA - 2018// TI - Loss of XIST in breast Cancer activates MSN-c-met and reprograms microglia via Exosomal miRNA to promote brain metastasis JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-18-1102 DO - 10.1158/0008-5472.CAN-18-1102 ID - Xing2018 ER - TY - JOUR AU - Karagiannis, G. S. AU - Condeelis, J. S. AU - Oktay, M. H. PY - 2019 DA - 2019// TI - Chemotherapy-induced metastasis: molecular mechanisms, clinical manifestations, Therapeutic Interventions JO - Cancer Res VL - 79 UR - https://doi.org/10.1158/0008-5472.CAN-19-1147 DO - 10.1158/0008-5472.CAN-19-1147 ID - Karagiannis2019 ER - TY - JOUR AU - Shao, L. N. AU - Zhu, B. S. AU - Xing, C. G. AU - Yang, X. D. AU - Young, W. AU - Cao, J. P. PY - 2016 DA - 2016// TI - Effects of autophagy regulation of tumor-associated macrophages on radiosensitivity of colorectal cancer cells JO - Mol Med Rep VL - 13 UR - https://doi.org/10.3892/mmr.2016.4820 DO - 10.3892/mmr.2016.4820 ID - Shao2016 ER - TY - JOUR AU - Yang, C. AU - Qin, S. PY - 2018 DA - 2018// TI - Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma JO - Cancer Med. VL - 7 UR - https://doi.org/10.1002/cam4.1664 DO - 10.1002/cam4.1664 ID - Yang2018 ER - TY - JOUR AU - Grither, W. R. AU - Longmore, G. D. PY - 2018 DA - 2018// TI - Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain JO - Proc Natl Acad Sci U S A VL - 115 UR - https://doi.org/10.1073/pnas.1805020115 DO - 10.1073/pnas.1805020115 ID - Grither2018 ER - TY - JOUR AU - Lee, H. M. AU - Lee, E. AU - Yeo, S. Y. PY - 2018 DA - 2018// TI - Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis JO - Investig New Drugs VL - 36 UR - https://doi.org/10.1007/s10637-017-0547-8 DO - 10.1007/s10637-017-0547-8 ID - Lee2018 ER - TY - JOUR AU - Takigawa, H. AU - Kitadai, Y. AU - Shinagawa, K. PY - 2016 DA - 2016// TI - Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12907 DO - 10.1111/cas.12907 ID - Takigawa2016 ER - TY - JOUR AU - Wei, S. C. AU - Duffy, C. R. AU - Allison, J. P. PY - 2018 DA - 2018// TI - Fundamental mechanisms of immune checkpoint blockade therapy JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0367 DO - 10.1158/2159-8290.CD-18-0367 ID - Wei2018 ER - TY - JOUR AU - Zhang, P. AU - Xiong, X. AU - Rolfo, C. PY - 2020 DA - 2020// TI - Mechanism- and immune landscape-based ranking of therapeutic responsiveness of 22 major human cancers to next generation anti-CTLA-4 antibodies JO - Cancers (Basel) VL - 12 UR - https://doi.org/10.3390/cancers12020284 DO - 10.3390/cancers12020284 ID - Zhang2020 ER - TY - JOUR AU - Liu, Y. AU - Zheng, P. PY - 2020 DA - 2020// TI - Preserving the CTLA-4 checkpoint for safer and more effective Cancer immunotherapy JO - Trends Pharmacol Sci VL - 41 UR - https://doi.org/10.1016/j.tips.2019.11.003 DO - 10.1016/j.tips.2019.11.003 ID - Liu2020 ER - TY - JOUR AU - Poggio, M. AU - Hu, T. AU - Pai, C. C. PY - 2019 DA - 2019// TI - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory JO - Cell VL - 177 UR - https://doi.org/10.1016/j.cell.2019.02.016 DO - 10.1016/j.cell.2019.02.016 ID - Poggio2019 ER - TY - JOUR AU - Tauriello, D. V. F. AU - Palomo-Ponce, S. AU - Stork, D. PY - 2018 DA - 2018// TI - TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis JO - Nature. VL - 554 UR - https://doi.org/10.1038/nature25492 DO - 10.1038/nature25492 ID - Tauriello2018 ER - TY - JOUR AU - Xu, X. AU - Ho, W. AU - Zhang, X. AU - Bertrand, N. AU - Farokhzad, O. PY - 2015 DA - 2015// TI - Cancer nanomedicine: from targeted delivery to combination therapy JO - Trends Mol Med VL - 21 UR - https://doi.org/10.1016/j.molmed.2015.01.001 DO - 10.1016/j.molmed.2015.01.001 ID - Xu2015 ER - TY - JOUR AU - Shi, D. AU - Bedford, N. M. AU - Cho, H. S. PY - 2011 DA - 2011// TI - Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics JO - Small. VL - 7 UR - https://doi.org/10.1002/smll.201100436 DO - 10.1002/smll.201100436 ID - Shi2011 ER - TY - JOUR AU - Zhang, F. AU - Stephan, S. B. AU - Ene, C. I. AU - Smith, T. T. AU - Holland, E. C. AU - Stephan, M. T. PY - 2018 DA - 2018// TI - Nanoparticles that reshape the tumor milieu create a therapeutic window for effective T-cell therapy in solid malignancies JO - Cancer Res VL - 78 ID - Zhang2018 ER - TY - JOUR AU - Jiang, T. AU - Chen, L. AU - Huang, Y. PY - 2019 DA - 2019// TI - Metformin and Docosahexaenoic acid hybrid micelles for Premetastatic niche modulation and tumor metastasis suppression JO - Nano Lett VL - 19 UR - https://doi.org/10.1021/acs.nanolett.9b00495 DO - 10.1021/acs.nanolett.9b00495 ID - Jiang2019 ER - TY - JOUR AU - Chen, B. AU - Dai, W. AU - Mei, D. PY - 2016 DA - 2016// TI - Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system JO - J Control Release VL - 241 UR - https://doi.org/10.1016/j.jconrel.2016.09.014 DO - 10.1016/j.jconrel.2016.09.014 ID - Chen2016 ER - TY - JOUR AU - Zhen, Z. AU - Tang, W. AU - Wang, M. PY - 2017 DA - 2017// TI - Protein Nanocage mediated fibroblast-activation protein targeted Photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control JO - Nano Lett VL - 17 UR - https://doi.org/10.1021/acs.nanolett.6b04150 DO - 10.1021/acs.nanolett.6b04150 ID - Zhen2017 ER - TY - JOUR AU - Lin, Y. G. AU - Kunnumakkara, A. B. AU - Nair, A. PY - 2007 DA - 2007// TI - Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3072 DO - 10.1158/1078-0432.CCR-06-3072 ID - Lin2007 ER - TY - JOUR AU - Bao, B. AU - Ali, S. AU - Ahmad, A. PY - 2012 DA - 2012// TI - Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0050165 DO - 10.1371/journal.pone.0050165 ID - Bao2012 ER - TY - JOUR AU - Basak, S. K. AU - Bera, A. AU - Yoon, A. J. PY - 2020 DA - 2020// TI - A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes JO - Cancer. VL - 126 UR - https://doi.org/10.1002/cncr.32644 DO - 10.1002/cncr.32644 ID - Basak2020 ER - TY - STD TI - Choi YH, Han DH, Kim SW, et al. A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate. 2019;79(6):614–21. ID - ref113 ER - TY - JOUR AU - Zhuang, H. AU - Dai, X. AU - Zhang, X. AU - Mao, Z. AU - Huang, H. PY - 2020 DA - 2020// TI - Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8+ T cytotoxic function against gastric cancer JO - Biomed Pharmacother VL - 121 UR - https://doi.org/10.1016/j.biopha.2019.109636 DO - 10.1016/j.biopha.2019.109636 ID - Zhuang2020 ER - TY - JOUR AU - Li, H. AU - Huang, N. AU - Zhu, W. PY - 2018 DA - 2018// TI - Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2 JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-018-4299-4 DO - 10.1186/s12885-018-4299-4 ID - Li2018 ER - TY - JOUR AU - Huang, C. AU - Wang, X. L. AU - Qi, F. F. AU - Pang, Z. L. PY - 2020 DA - 2020// TI - Berberine inhibits epithelial-mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF-β signalling JO - J Cell Commun Signal VL - 14 UR - https://doi.org/10.1007/s12079-019-00525-7 DO - 10.1007/s12079-019-00525-7 ID - Huang2020 ER - TY - JOUR AU - Li, M. AU - Yue, G. G. AU - Song, L. H. PY - 2018 DA - 2018// TI - Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway JO - Biochem Pharmacol VL - 150 UR - https://doi.org/10.1016/j.bcp.2018.02.017 DO - 10.1016/j.bcp.2018.02.017 ID - Li2018 ER - TY - JOUR AU - Jin, Y. AU - Meng, X. AU - Qiu, Z. AU - Su, Y. AU - Yu, P. AU - Qu, P. PY - 2018 DA - 2018// TI - Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris JO - Saudi J Biol Sci VL - 25 UR - https://doi.org/10.1016/j.sjbs.2018.05.016 DO - 10.1016/j.sjbs.2018.05.016 ID - Jin2018 ER - TY - JOUR AU - Wei, Y. AU - Li, M. AU - Cui, S. PY - 2016 DA - 2016// TI - Shikonin inhibits the proliferation of human breast Cancer cells by reducing tumor-derived Exosomes JO - Molecules. VL - 21 UR - https://doi.org/10.3390/molecules21060777 DO - 10.3390/molecules21060777 ID - Wei2016 ER - TY - JOUR AU - Sun, C. AU - Fang, Y. AU - Yin, J. PY - 2017 DA - 2017// TI - Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aal5148 DO - 10.1126/scitranslmed.aal5148 ID - Sun2017 ER - TY - JOUR AU - Lord, C. J. AU - Ashworth, A. PY - 2017 DA - 2017// TI - PARP inhibitors: synthetic lethality in the clinic JO - Science. VL - 355 UR - https://doi.org/10.1126/science.aam7344 DO - 10.1126/science.aam7344 ID - Lord2017 ER - TY - JOUR AU - Guo, S. AU - Lin, C. M. AU - Xu, Z. AU - Miao, L. AU - Wang, Y. AU - Huang, L. PY - 2014 DA - 2014// TI - Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation JO - ACS Nano VL - 8 UR - https://doi.org/10.1021/nn5010815 DO - 10.1021/nn5010815 ID - Guo2014 ER - TY - JOUR AU - Jiao, S. AU - Xia, W. AU - Yamaguchi, H. PY - 2017 DA - 2017// TI - PARP inhibitor Upregulates PD-L1 expression and enhances Cancer-associated immunosuppression JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-3215 DO - 10.1158/1078-0432.CCR-16-3215 ID - Jiao2017 ER - TY - JOUR AU - Reisländer, T. AU - Lombardi, E. P. AU - Groelly, F. J. PY - 2019 DA - 2019// TI - BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors JO - Nat Commun VL - 10 UR - https://doi.org/10.1038/s41467-019-11048-5 DO - 10.1038/s41467-019-11048-5 ID - Reisländer2019 ER - TY - JOUR AU - Gou, H. F. AU - Zhou, L. AU - Huang, J. AU - Chen, X. C. PY - 2018 DA - 2018// TI - Intraperitoneal oxaliplatin administration inhibits the tumor immunosuppressive microenvironment in an abdominal implantation model of colon cancer JO - Mol Med Rep VL - 18 ID - Gou2018 ER - TY - JOUR AU - Zheng, B. AU - Ren, T. AU - Huang, Y. AU - Guo, W. PY - 2018 DA - 2018// TI - Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3 JO - Biochem Biophys Res Commun VL - 495 UR - https://doi.org/10.1016/j.bbrc.2017.12.032 DO - 10.1016/j.bbrc.2017.12.032 ID - Zheng2018 ER - TY - JOUR AU - Huang, M. AU - Huang, B. AU - Li, G. AU - Zeng, S. PY - 2018 DA - 2018// TI - Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell JO - BMC Gastroenterol VL - 18 UR - https://doi.org/10.1186/s12876-018-0870-3 DO - 10.1186/s12876-018-0870-3 ID - Huang2018 ER - TY - JOUR AU - Uribesalgo, I. AU - Hoffmann, D. AU - Zhang, Y. PY - 2019 DA - 2019// TI - Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy JO - EMBO Mol Med VL - 11 UR - https://doi.org/10.15252/emmm.201809266 DO - 10.15252/emmm.201809266 ID - Uribesalgo2019 ER - TY - JOUR AU - Hadla, M. AU - Palazzolo, S. AU - Corona, G. PY - 2016 DA - 2016// TI - Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models JO - Nanomedicine (Lond) VL - 11 UR - https://doi.org/10.2217/nnm-2016-0154 DO - 10.2217/nnm-2016-0154 ID - Hadla2016 ER - TY - JOUR AU - Li, Y. AU - Gao, Y. AU - Gong, C. PY - 2018 DA - 2018// TI - A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer JO - Nanomedicine. VL - 14 UR - https://doi.org/10.1016/j.nano.2018.05.020 DO - 10.1016/j.nano.2018.05.020 ID - Li2018 ER - TY - JOUR AU - Sternberg, C. AU - Armstrong, A. AU - Pili, R. PY - 2016 DA - 2016// TI - Randomized, double-blind, placebo-controlled phase III study of Tasquinimod in men with metastatic castration-resistant prostate Cancer JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.66.9697 DO - 10.1200/JCO.2016.66.9697 ID - Sternberg2016 ER - TY - JOUR AU - Karasaki, T. AU - Nagayama, K. AU - Kuwano, H. PY - 2017 DA - 2017// TI - An Immunogram for the Cancer-immunity cycle: towards personalized immunotherapy of lung Cancer JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2017.01.005 DO - 10.1016/j.jtho.2017.01.005 ID - Karasaki2017 ER - TY - JOUR AU - Mariathasan, S. AU - Turley, S. J. AU - Nickles, D. PY - 2018 DA - 2018// TI - TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells JO - Nature. VL - 554 UR - https://doi.org/10.1038/nature25501 DO - 10.1038/nature25501 ID - Mariathasan2018 ER - TY - JOUR AU - Gravina, G. L. AU - Mancini, A. AU - Muzi, P. PY - 2015 DA - 2015// TI - CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models JO - Prostate. VL - 75 UR - https://doi.org/10.1002/pros.23007 DO - 10.1002/pros.23007 ID - Gravina2015 ER - TY - JOUR AU - Georgoudaki, A. M. AU - Prokopec, K. E. AU - Boura, V. F. PY - 2016 DA - 2016// TI - Reprogramming tumor-associated macrophages by antibody targeting inhibits Cancer progression and metastasis JO - Cell Rep VL - 15 UR - https://doi.org/10.1016/j.celrep.2016.04.084 DO - 10.1016/j.celrep.2016.04.084 ID - Georgoudaki2016 ER - TY - JOUR AU - Marsh, J. L. AU - Jackman, C. P. AU - Tang, S. N. AU - Shankar, S. AU - Srivastava, R. K. PY - 2014 DA - 2014// TI - Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment JO - Front Biosci (Landmark Ed) VL - 19 UR - https://doi.org/10.2741/4198 DO - 10.2741/4198 ID - Marsh2014 ER - TY - JOUR AU - Jeffery, J. J. AU - Lux, K. AU - Vogel, J. S. PY - 2014 DA - 2014// TI - Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging JO - Exp Biol Med (Maywood) VL - 239 UR - https://doi.org/10.1177/1535370214522588 DO - 10.1177/1535370214522588 ID - Jeffery2014 ER - TY - JOUR AU - Emens, L. A. PY - 2018 DA - 2018// TI - Breast Cancer immunotherapy: facts and hopes JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-16-3001 DO - 10.1158/1078-0432.CCR-16-3001 ID - Emens2018 ER - TY - JOUR AU - Savas, P. AU - Salgado, R. AU - Denkert, C. PY - 2016 DA - 2016// TI - Clinical relevance of host immunity in breast cancer: from TILs to the clinic JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2015.215 DO - 10.1038/nrclinonc.2015.215 ID - Savas2016 ER - TY - JOUR AU - Cimino-Mathews, A. AU - Thompson, E. AU - Taube, J. M. PY - 2016 DA - 2016// TI - PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas JO - Hum Pathol VL - 47 UR - https://doi.org/10.1016/j.humpath.2015.09.003 DO - 10.1016/j.humpath.2015.09.003 ID - Cimino-Mathews2016 ER - TY - JOUR AU - Li, X. AU - Li, M. AU - Lian, Z. PY - 2016 DA - 2016// TI - Prognostic role of programmed death Ligand-1 expression in breast Cancer: a systematic review and meta-analysis JO - Target Oncol VL - 11 UR - https://doi.org/10.1007/s11523-016-0451-8 DO - 10.1007/s11523-016-0451-8 ID - Li2016 ER - TY - JOUR AU - Tokito, T. AU - Azuma, K. AU - Kawahara, A. PY - 2016 DA - 2016// TI - Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy JO - Eur J Cancer VL - 55 UR - https://doi.org/10.1016/j.ejca.2015.11.020 DO - 10.1016/j.ejca.2015.11.020 ID - Tokito2016 ER - TY - JOUR AU - Matsushita, H. AU - Sato, Y. AU - Karasaki, T. PY - 2016 DA - 2016// TI - Neoantigen load, antigen presentation machinery, and immune signatures determine prognosis in clear cell renal cell carcinoma JO - Cancer Immunol Res. VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0225 DO - 10.1158/2326-6066.CIR-15-0225 ID - Matsushita2016 ER - TY - JOUR AU - Taube, J. M. AU - Young, G. D. AU - McMiller, T. L. PY - 2015 DA - 2015// TI - Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0244 DO - 10.1158/1078-0432.CCR-15-0244 ID - Taube2015 ER - TY - JOUR AU - Liu, M. AU - Song, W. AU - Huang, L. PY - 2019 DA - 2019// TI - Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy JO - Cancer Lett VL - 448 UR - https://doi.org/10.1016/j.canlet.2019.01.032 DO - 10.1016/j.canlet.2019.01.032 ID - Liu2019 ER - TY - JOUR AU - Zhou, L. AU - Wang, H. AU - Li, Y. PY - 2018 DA - 2018// TI - Stimuli-responsive Nanomedicines for overcoming Cancer multidrug resistance JO - Theranostics. VL - 8 UR - https://doi.org/10.7150/thno.22679 DO - 10.7150/thno.22679 ID - Zhou2018 ER - TY - STD TI - Wan G, Chen B, Li L, et al. Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy [published correction appears in biomaterials. Biomaterials. 2018;155:25–40. ID - ref147 ER - TY - JOUR AU - Uthaman, S. AU - Huh, K. M. AU - Park, I. K. PY - 2018 DA - 2018// TI - Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications JO - Biomater Res VL - 22 UR - https://doi.org/10.1186/s40824-018-0132-z DO - 10.1186/s40824-018-0132-z ID - Uthaman2018 ER - TY - JOUR AU - Sun, T. AU - Zhang, Y. S. AU - Pang, B. AU - Hyun, D. C. AU - Yang, M. AU - Xia, Y. PY - 2014 DA - 2014// TI - Engineered nanoparticles for drug delivery in cancer therapy JO - Angew Chem Int Ed Engl VL - 53 ID - Sun2014 ER - TY - JOUR AU - Din, F. U. AU - Aman, W. AU - Ullah, I. PY - 2017 DA - 2017// TI - Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors JO - Int J Nanomedicine VL - 12 UR - https://doi.org/10.2147/IJN.S146315 DO - 10.2147/IJN.S146315 ID - Din2017 ER - TY - JOUR AU - Zhang, T. AU - Liu, H. AU - Li, Y. PY - 2019 DA - 2019// TI - A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition JO - Acta Biomater VL - 99 UR - https://doi.org/10.1016/j.actbio.2019.09.001 DO - 10.1016/j.actbio.2019.09.001 ID - Zhang2019 ER - TY - JOUR AU - Wilken, R. AU - Veena, M. S. AU - Wang, M. B. AU - Srivatsan, E. S. PY - 2011 DA - 2011// TI - Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma JO - Mol Cancer VL - 10 UR - https://doi.org/10.1186/1476-4598-10-12 DO - 10.1186/1476-4598-10-12 ID - Wilken2011 ER - TY - JOUR AU - Zhao, Y. AU - Yao, J. AU - Wu, X. P. PY - 2015 DA - 2015// TI - Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway JO - Mol Carcinog VL - 54 UR - https://doi.org/10.1002/mc.22182 DO - 10.1002/mc.22182 ID - Zhao2015 ER - TY - JOUR AU - Liu, H. AU - Shen, M. AU - Zhao, D. PY - 2019 DA - 2019// TI - The effect of Triptolide-loaded Exosomes on the proliferation and apoptosis of human ovarian Cancer SKOV3 cells JO - Biomed Res Int VL - 2019 ID - Liu2019 ER - TY - JOUR AU - Zhong, W. AU - Yang, W. AU - Qin, Y. PY - 2019 DA - 2019// TI - 6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression JO - J Exp Clin Cancer Res VL - 38 UR - https://doi.org/10.1186/s13046-019-1291-z DO - 10.1186/s13046-019-1291-z ID - Zhong2019 ER - TY - JOUR AU - Yang, Y. AU - Zhang, L. AU - La, X. AU - Li, Z. AU - Li, H. AU - Guo, S. PY - 2019 DA - 2019// TI - Salvianolic acid a inhibits tumor-associated angiogenesis by blocking GRP78 secretion JO - Naunyn Schmiedeberg's Arch Pharmacol VL - 392 UR - https://doi.org/10.1007/s00210-018-1585-2 DO - 10.1007/s00210-018-1585-2 ID - Yang2019 ER - TY - JOUR AU - Zhuang, M. AU - Xin, G. AU - Wei, Z. PY - 2019 DA - 2019// TI - Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S202225 DO - 10.2147/CMAR.S202225 ID - Zhuang2019 ER - TY - JOUR AU - Heeren, A. M. AU - Luijk, I. F. AU - Lakeman, J. PY - 2019 DA - 2019// TI - Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer JO - Cancer Immunol Immunother VL - 68 UR - https://doi.org/10.1007/s00262-019-02412-x DO - 10.1007/s00262-019-02412-x ID - Heeren2019 ER - TY - JOUR AU - Kitano, H. AU - Kitadai, Y. AU - Teishima, J. PY - 2017 DA - 2017// TI - Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma JO - Cancer Med VL - 6 UR - https://doi.org/10.1002/cam4.1124 DO - 10.1002/cam4.1124 ID - Kitano2017 ER - TY - JOUR AU - Iwamoto, H. AU - Abe, M. AU - Yang, Y. PY - 2018 DA - 2018// TI - Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance JO - Cell Metab VL - 28 UR - https://doi.org/10.1016/j.cmet.2018.05.005 DO - 10.1016/j.cmet.2018.05.005 ID - Iwamoto2018 ER - TY - JOUR AU - Ashworth, A. AU - Lord, C. J. AU - Reis-Filho, J. S. PY - 2011 DA - 2011// TI - Genetic interactions in cancer progression and treatment JO - Cell. VL - 145 UR - https://doi.org/10.1016/j.cell.2011.03.020 DO - 10.1016/j.cell.2011.03.020 ID - Ashworth2011 ER - TY - JOUR AU - Golan, T. AU - Hammel, P. AU - Reni, M. PY - 2019 DA - 2019// TI - Maintenance Olaparib for Germline BRCA-mutated metastatic pancreatic Cancer JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1903387 DO - 10.1056/NEJMoa1903387 ID - Golan2019 ER - TY - JOUR AU - Howells, L. M. AU - Iwuji, C. O. O. AU - Irving, G. R. B. PY - 2019 DA - 2019// TI - Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal Cancer in a randomized phase IIa trial JO - J Nutr VL - 149 UR - https://doi.org/10.1093/jn/nxz029 DO - 10.1093/jn/nxz029 ID - Howells2019 ER - TY - JOUR AU - Sheng, X. AU - Sun, X. AU - Sun, K. AU - Sui, H. AU - Qin, J. AU - Li, Q. PY - 2016 DA - 2016// TI - Inhibitory effect of bufalin combined with hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells JO - Int J Oncol VL - 49 UR - https://doi.org/10.3892/ijo.2016.3667 DO - 10.3892/ijo.2016.3667 ID - Sheng2016 ER - TY - JOUR AU - Wang, H. AU - Zhang, C. AU - Chi, H. AU - Meng, Z. PY - 2018 DA - 2018// TI - Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling JO - Int J Oncol VL - 52 ID - Wang2018 ER - TY - JOUR AU - Wang, J. AU - Tian, L. AU - Khan, M. N. PY - 2018 DA - 2018// TI - Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness JO - Cancer Lett VL - 415 UR - https://doi.org/10.1016/j.canlet.2017.11.037 DO - 10.1016/j.canlet.2017.11.037 ID - Wang2018 ER - TY - JOUR AU - Pang, N. AU - Li, J. AU - Sun, A. AU - Yang, Z. AU - Cheng, S. AU - Qi, X. R. PY - 2018 DA - 2018// TI - Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor JO - Int J Nanomedicine VL - 13 UR - https://doi.org/10.2147/IJN.S171224 DO - 10.2147/IJN.S171224 ID - Pang2018 ER -